The expression of SLIT3 is downregulated in lung tumor tissues and silencing of SLIT3 in lung cancer cells induces epithelial-mesenchymal transition by downregulating E-cadherin and enhancing MMP2 and MMP9 expression [35]. Here, SLIT3 is linked to lung carcinoma.